Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Diabetes Drug Shakeup: What You Need to Know About New FDA Warnings
Motley Fool
Tue, 04/19/16 - 09:50 am
Tags:
FDA, diabetes, AstraZeneca, Takeda, Nesina, Onglyza, Eli Lilly, JNJ, Trajenta, Jardiance, Invokana
Report: AstraZeneca considering bid for cancer biotech Medivation
BioPharma Dive
Mon, 04/18/16 - 09:44 am
Tags:
AstraZeneca, Medivation, Sanofi, M&A, Xtandi
Diabetes drugs fuel cancer spread in mouse study
Stat
Wed, 04/13/16 - 10:26 pm
Tags:
diabetes, cancer, Merck, Januvia, AstraZeneca, Onglyza
Two drug makers complain India is thwarting licenses for selling generics
Stat
Wed, 04/13/16 - 11:46 am
Tags:
India, Lee Pharma, BDR Pharma, generics, Sprycel, Bristol-Myers Squibb, AstraZeneca, Onglyza
Medivation: Biotech’s Most Wanted?
Barron's
Wed, 04/13/16 - 09:53 am
Tags:
Medivation, M&A, Amgen, Gilead Sciences, Sanofi, AstraZeneca
3 Nominations for Big Pharma's Riskiest Pipeline -- and Why They Qualify
Motley Fool
Tue, 04/12/16 - 10:37 am
Tags:
GSK, oncology, Bristol-Myers Squibb, AstraZeneca
3 Big Battles Brewing in Biotech
Motley Fool
Sun, 04/10/16 - 01:50 pm
Tags:
AstraZeneca, ZS-9, Relypsa, Veltassa, Synergy Pharmaceuticals, plecanatide, Linzess, Ironwood, Allergan, Incyte, Eli Lilly, baricitinib, AbbVie, Humira
AstraZeneca, Eli Lilly move closely watched BACE Alzheimer's trial into PhIII
Fierce Biotech
Fri, 04/8/16 - 10:59 am
Tags:
AstraZeneca, Eli Lilly, BACE inhibitors, Alzheimer's disease, AZD3293
Biotechnology company Relypsa explores potential sale-sources
Yahoo/Reuters
Fri, 04/8/16 - 09:40 am
Tags:
Relypsa, M&A, AstraZeneca, hyperkalemia
FDA warns on heart failure risk associated with Onglyza, Nesina
BioPharma Dive
Wed, 04/6/16 - 10:13 pm
Tags:
FDA, heart failure, Onglyza, Nesina, AstraZeneca, Takeda, diabetes
Would Pfizer and AstraZeneca Both Revisit That $100 Billion Deal?
Forbes
Tue, 04/5/16 - 08:57 am
Tags:
Pfizer, AstraZeneca, M&A
Cholesterol-lowering statins cut heart disease risk in people with slightly high blood pressure
Stat
Sat, 04/2/16 - 02:10 pm
Tags:
statins, hypertension, Crestor, AstraZeneca
What AstraZeneca Heart Drug Failure Means
Bidness, ETC
Fri, 03/25/16 - 09:32 am
Tags:
AstraZeneca, heart failure, Brilinta
AstraZeneca heart drug fails in key stroke trial
Yahoo/Reuters
Wed, 03/23/16 - 09:54 am
Tags:
AstraZeneca, stroke, clinical trials, Brilinta
Orphan Drugs On a Roll, A Look Into the 2016 Orphan Space
Yahoo/Accesswire
Mon, 03/21/16 - 12:12 pm
Tags:
AstraZeneca, orphan drugs, ProNai, Delmar Pharma, Bellicum
AstraZeneca weighs linking CEO pay more closely to sales target
Yahoo/Reuters
Mon, 03/14/16 - 10:30 am
Tags:
AstraZeneca, Pharma CEOs, executive pay, Pascal Soriot
AstraZeneca's mesothelioma drug fails monotherapy testing
BioPharma Dive
Thu, 03/3/16 - 10:38 am
Tags:
AstraZeneca, mesothelioma, clinical trials, tremelimumab
Drugmakers partner in immuno-oncology, to better capture market share
Medical Marketing and Media
Wed, 03/2/16 - 11:00 am
Tags:
Opdivo, immuno-oncology, Bristol-Myers Squibb, Eli Lilly, Merck, Roche, AstraZeneca, Novartis
AstraZeneca reels in $500M from two China deals
Bizjournals.com
Tue, 03/1/16 - 12:01 am
Tags:
AstraZeneca, China, China Medical System Holdings
Closely watched AstraZeneca cancer drug fails in mesothelioma
Reuters
Mon, 02/29/16 - 11:13 am
Tags:
AstraZeneca, mesothelioma, clinical trials, tremelimumab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.